Twitter | Pretraživanje | |
Innovation Endeavors
Big news out of company ! Congrats on achieving 94% Sens and 94% Spec in Stage I and II CRC Screening from Blood in a fully prospective cohort. A huge step forward in the detection of early-stage colorectal cancer
Freenome, a privately-held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection through a routine b
Business Wire Business Wire @BusinessWire
Reply Retweet Označi sa "sviđa mi se" More